المؤلفون: Petrillo A, Tirino G, Zito Marino F, Pompella L, Sabetta R, Panarese I, Pappalardo A, Caterino M, Ventriglia A, Laterza MM, Morgillo F, Orditura M, Ciardiello F, Franco R, De Vita F

المصدر: OncoTargets and Therapy, Vol Volume 13, Pp 867-876 (2020)

مصطلحات موضوعية: immune-checkpoint inhibitors, nivolumab, immunotherapy, third line, pd-l1, msi, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.comTest/nivolumab-in-heavily-pretreated-metastatic-gastric-cancer-patients-rea-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930Test

الوصول الحر: https://doaj.org/article/e21c61e06e134effab673c8c0810d538Test

المؤلفون: Garassino M. C., Crino L., Catino A., Ardizzoni A., Cortesi E., Cappuzzo F., Bordi P., Calabro L., Barbieri F., Santo A., Altavilla G., Ambrosio F., Mini E., Vasile E., Morgillo F., Scoppola A., Bengala C., Follador A., Tedde N., Giannarelli D., Lo Russo G., Vitiello F.

المساهمون: Garassino, M. C., Crino, L., Catino, A., Ardizzoni, A., Cortesi, E., Cappuzzo, F., Bordi, P., Calabro, L., Barbieri, F., Santo, A., Altavilla, G., Ambrosio, F., Mini, E., Vasile, E., Morgillo, F., Scoppola, A., Bengala, C., Follador, A., Tedde, N., Giannarelli, D., Lo Russo, G., Vitiello, F.

مصطلحات موضوعية: expanded access program, italian, never-smoker, nivolumab, squamous non-small cell lung cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30486741; volume:40; issue:11; numberofpages:8; journal:TUMOR BIOLOGY; http://hdl.handle.net/11573/1291158Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85057530732

الإتاحة: https://doi.org/10.1177/1010428318815047Test
http://hdl.handle.net/11573/1291158Test

المؤلفون: Petrillo A., Tirino G., Marino F. Z., Pompella L., Sabetta R., Panarese I., Pappalardo A., Caterino M., Ventriglia A., Laterza M. M., Morgillo F., Orditura M., Ciardiello F., Franco R., De Vita F., ZITO MARINO, Federica

المساهمون: Petrillo, A., Tirino, G., Marino, F. Z., Pompella, L., Sabetta, R., Panarese, I., Pappalardo, A., Caterino, M., Ventriglia, A., Laterza, M. M., Morgillo, F., Orditura, M., Ciardiello, F., Franco, R., De Vita, F., ZITO MARINO, Federica

مصطلحات موضوعية: Immune-checkpoint inhibitor, Immunotherapy, MSI, Nivolumab, PD-L1, Third line

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32099391; info:eu-repo/semantics/altIdentifier/wos/WOS:000509686400001; volume:13; firstpage:867; lastpage:876; numberofpages:10; journal:ONCOTARGETS AND THERAPY; http://hdl.handle.net/11591/429206Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85078885353

الإتاحة: https://doi.org/10.2147/OTT.S229813Test
http://hdl.handle.net/11591/429206Test

المؤلفون: Petrillo A., Tirino G., Marino F. Z., Pompella L., Sabetta R., Panarese I., Pappalardo A., Caterino M., Ventriglia A., Laterza M. M., Morgillo F., Orditura M., Ciardiello F., Franco R., De Vita F., ZITO MARINO, Federica

المساهمون: Petrillo, A., Tirino, G., Marino, F. Z., Pompella, L., Sabetta, R., Panarese, I., Pappalardo, A., Caterino, M., Ventriglia, A., Laterza, M. M., Morgillo, F., Orditura, M., Ciardiello, F., Franco, R., De Vita, F., ZITO MARINO, Federica

المصدر: OncoTargets and therapy

مصطلحات موضوعية: nivolumab, PD-L1, Immune-checkpoint inhibitor, immune-checkpoint inhibitors, immunotherapy, third line, MSI, Original Research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::824eda5978d38faab64a80b80dea3affTest
https://pubmed.ncbi.nlm.nih.gov/32099391Test

المؤلفون: Napolitano, S., Brancaccio, G., Argenziano, G., Martinelli, E., Morgillo, F., Ciardiello, F., Troiani, T.

المساهمون: Napolitano, S., Brancaccio, G., Argenziano, G., Martinelli, E., Morgillo, F., Ciardiello, F., Troiani, T.

مصطلحات موضوعية: Adjuvant treatment, Melanoma, New strategie, Nivolumab, Pembrolizumab, Target therapy, Oncology, Radiology, Nuclear Medicine and Imaging

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29957365; info:eu-repo/semantics/altIdentifier/wos/WOS:000446950300011; volume:69; firstpage:101; lastpage:111; numberofpages:11; journal:CANCER TREATMENT REVIEWS; http://hdl.handle.net/11591/393163Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85048968986; http://www.elsevier.com/inca/publications/store/6/2/3/0/2/2/index.httTest

الإتاحة: https://doi.org/10.1016/j.ctrv.2018.06.003Test
http://hdl.handle.net/11591/393163Test
http://www.elsevier.com/inca/publications/store/6/2/3/0/2/2/index.httTest

المؤلفون: Califano R., Kerr K., Morgan R. D., Russo G. L., Garassino M., Morgillo F., Rossi A.

المساهمون: Califano, R., Kerr, K., Morgan, R. D., Russo, G. L., Garassino, M., Morgillo, F., Rossi, A.

مصطلحات موضوعية: Atezolizumab, CTLA-4, Durvalumab, Immune checkpoint, Nivolumab, Non-small cell lung cancer, PD-1, PD-L1, Pembrolizumab, Antibodies, Monoclonal, Humanized, Carcinoma, Non-Small-Cell Lung, Cell Cycle Checkpoint, Human, Prognosi, Immunotherapy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27484062; info:eu-repo/semantics/altIdentifier/wos/WOS:000380670800007; volume:18; issue:9; firstpage:59; journal:CURRENT ONCOLOGY REPORTS; http://hdl.handle.net/11591/424050Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84982701921; http://www.springerlink.com/content/1523-3790Test/

الإتاحة: https://doi.org/10.1007/s11912-016-0544-7Test
http://hdl.handle.net/11591/424050Test
http://www.springerlink.com/content/1523-3790Test/

المؤلفون: Floriana Morgillo, Giuseppe Argenziano, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello, Gabriella Brancaccio, Stefania Napolitano

المساهمون: Napolitano, S., Brancaccio, G., Argenziano, G., Martinelli, E., Morgillo, F., Ciardiello, F., Troiani, T.

المصدر: Cancer Treatment Reviews. 69:101-111

مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Ipilimumab, Target therapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Adjuvant therapy, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Adverse effect, Melanoma, business.industry, MEK inhibitor, Antibodies, Monoclonal, General Medicine, Immunotherapy, Adjuvant treatment, medicine.disease, Neoadjuvant Therapy, Nivolumab, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, New strategie, business, Pembrolizumab, Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03039eaf65653936160bcafb879cff2fTest
https://doi.org/10.1016/j.ctrv.2018.06.003Test

المؤلفون: Marina Chiara Garassino, Annamaria Catino, Luana Calabrò, Francesca Ambrosio, Carmelo Bengala, Alessandro Follador, Fabiana Vitiello, Floriana Morgillo, Lucio Crinò, Paola Bordi, Enrico Mini, Giuseppe Lo Russo, Enrico Vasile, Andrea Ardizzoni, Antonio Santo, Federico Cappuzzo, Alessandro Scoppola, Giuseppe Altavilla, Diana Giannarelli, Enrico Cortesi, Natale Tedde, Fausto Barbieri

المساهمون: Garassino, M. C., Crino, L., Catino, A., Ardizzoni, A., Cortesi, E., Cappuzzo, F., Bordi, P., Calabro, L., Barbieri, F., Santo, A., Altavilla, G., Ambrosio, F., Mini, E., Vasile, E., Morgillo, F., Scoppola, A., Bengala, C., Follador, A., Tedde, N., Giannarelli, D., Lo Russo, G., Vitiello, F., Garassino, Marina Chiara, Crinò, Lucio, Catino, Annamaria, Ardizzoni, Andrea, Cortesi, Enrico, Cappuzzo, Federico, Bordi, Paola, Calabrò, Luana, Barbieri, Fausto, Santo, Antonio, Altavilla, Giuseppe, Ambrosio, Francesca, Mini, Enrico, Vasile, Enrico, Morgillo, Floriana, Scoppola, Alessandro, Bengala, Carmelo, Follador, Alessandro, Tedde, Natale, Giannarelli, Diana, Lo Russo, Giuseppe, Vitiello, Fabiana

المصدر: Tumor Biology, Vol 40 (2018)

مصطلحات موضوعية: Oncology, Male, Cancer Research, Lung Neoplasms, medicine.medical_treatment, never-smokers, carcinoma, Health Services Accessibility, Cohort Studies, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 80 and over, Medicine, 030212 general & internal medicine, squamous non-small cell lung cancer, RC254-282, Aged, 80 and over, never-smoker, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Middle Aged, Prognosis, expanded access program, italian, nivolumab, Survival Rate, Nivolumab, 030220 oncology & carcinogenesis, Cohort, Carcinoma, Squamous Cell, Disease Progression, Female, Case-Control Studie, Human, Cohort study, Expanded access program, italian, never-smokers, nivolumab, squamous non-small cell lung cancer, adult, aged, aged, 80 and over, carcinoma, non-small-cell lung, squamous cell, case-control studies, cohort studies, disease progression, female, follow-up studies, humans, lung neoplasms, male, middle aged, nivolumab, non-smokers, Prognosis, survival rate, health services accessibility, Adult, medicine.medical_specialty, Italian, Prognosi, Follow-Up Studie, 03 medical and health sciences, Internal medicine, Humans, Survival rate, Aged, squamous cell, Expanded access program, business.industry, Case-control study, Immunotherapy, Non-Smokers, Lung Neoplasm, non-small-cell lung, Non-Smoker, Expanded access, Case-Control Studies, Squamous non-small cell lung cancer, Cohort Studie, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c642f7d451ab777c58a9f1fa409060Test
https://pubmed.ncbi.nlm.nih.gov/30486741Test

المؤلفون: Antonio Rossi, Giuseppe Lo Russo, Floriana Morgillo, Keith M. Kerr, Robert D. Morgan, Raffaele Califano, Marina Chiara Garassino

المساهمون: Califano, R., Kerr, K., Morgan, R. D., Russo, G. L., Garassino, M., Morgillo, F., Rossi, A.

المصدر: Current oncology reports. 18(9)

مصطلحات موضوعية: 0301 basic medicine, PD-L1, Prognosi, medicine.medical_treatment, Pembrolizumab, Bioinformatics, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Immune system, Atezolizumab, CTLA-4, Durvalumab, immune checkpoint, Nivolumab, non-small cell lung cancer, PD-1, antibodies, monoclonal, antibodies monoclonal, humanized, carcinoma, non-small-cell lung, cell cycle checkpoints, humans, prognosis, immunotherapy, oncology, Non-small cell lung cancer, Cell Cycle Checkpoint, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Lung cancer, business.industry, Antibodies, Monoclonal, Immunotherapy, Cell Cycle Checkpoints, medicine.disease, Prognosis, Immune checkpoint, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, business, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5f0c572b4c960ae26bbefac4583b5dTest
https://pubmed.ncbi.nlm.nih.gov/27484062Test